Lilly Provider Capability Assessment & Qualification Initiative

Lilly has partnered with Diligent Pharma to streamline their Provider discovery and qualification process.

As part of that initiative, Diligent will serve as a neutral third-party to help Lilly assess Providers’ technical capabilities and expertise. The data we collect on your services will enable Lilly to discover new Providers they may be interested in qualifying and onboarding. Lilly would like to evaluate your organization as a potential service Provider by having you complete Diligent Pharma’s RFI questionnaires.

Diligent Pharma is a tech-enabled services firm with a centralized platform of Provider qualification data. This centralized platform is being leveraged by both Sponsors and Providers to drive speed, efficiency, and compliance in the clinical trial service Provider qualification process.

Please fill out the information on this page, and Diligent Pharma will reach out to you to initiate the process. Lilly and Diligent Pharma appreciate your participation in this initiative.